Published in Mol Endocrinol on November 01, 1998
Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling. J Biol Chem (2011) 1.22
The repertoire of G protein-coupled receptors in the sea squirt Ciona intestinalis. BMC Evol Biol (2008) 1.04
Mapping peptide hormone-receptor interactions using a disulfide-trapping approach. Biochemistry (2008) 1.03
Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs. Br J Pharmacol (2014) 0.88
Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1). J Biol Chem (2008) 0.85
International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors. Pharmacol Rev (2015) 0.83
Recombinant expression and purification of the N-terminal extracellular domain of the parathyroid hormone receptor. Protein Expr Purif (2007) 0.79
Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation. Genes Brain Behav (2016) 0.75
An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature (1994) 8.60
A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science (1987) 4.09
Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A (1987) 3.06
Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology (2003) 2.84
Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest (1987) 2.41
Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology (2000) 2.18
Pre-proparathyroid hormone; amino acid sequence, chemical synthesis, and some biological studies of the precursor region. Proc Natl Acad Sci U S A (1978) 2.07
Highly selective agonists for substance P receptor subtypes. EMBO J (1986) 1.80
Air bags: trade-offs. N Engl J Med (1991) 1.66
Retrieval of intravascular foreign bodies: experience in 32 cases. AJR Am J Roentgenol (1995) 1.50
Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol (2001) 1.46
Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin. Proc Natl Acad Sci U S A (1985) 1.44
Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol Chem (1999) 1.42
Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N Engl J Med (1981) 1.41
Synthetic pre-proparathyroid hormone leader sequence inhibits cell-free processing of placental, parathyroid, and pituitary prehormones. J Biol Chem (1980) 1.40
Conformational studies of the synthetic precursor-specific region of preproparathyroid hormone. Proc Natl Acad Sci U S A (1980) 1.38
Human renal carcinoma expresses two messages encoding a parathyroid hormone-like peptide: evidence for the alternative splicing of a single-copy gene. Proc Natl Acad Sci U S A (1988) 1.36
The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol Endocrinol (2001) 1.35
Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein. Endocrinology (1993) 1.35
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem (2000) 1.34
Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism. Physiol Rev (1984) 1.31
Alterations in skeletal perfusion with simulated microgravity: a possible mechanism for bone remodeling. J Appl Physiol (1985) (2000) 1.31
A CLASS OF STATIONARY PROCESSES AND A CENTRAL LIMIT THEOREM. Proc Natl Acad Sci U S A (1956) 1.31
Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies. J Biol Chem (1998) 1.27
Parathyroid hormone-related protein in hypercalcaemia of malignancy. Clin Endocrinol (Oxf) (1989) 1.25
Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med (1997) 1.25
Malignant glaucoma. Surv Ophthalmol (1988) 1.24
Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor. J Biol Chem (2000) 1.21
Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood (1992) 1.19
Parathyroid hormone: chemistry, biosynthesis, and mode of action. Adv Protein Chem (1982) 1.19
Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci (2000) 1.19
Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int (1994) 1.18
Behavioural effects of receptor-specific substance P agonists. Pain (1987) 1.14
Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand. J Biol Chem (1986) 1.13
A new method of active immunisation to autologous human tumour tissue. Lancet (1967) 1.12
Initial experience with venous stents in exertional axillary-subclavian vein thrombosis. J Vasc Surg (1996) 1.12
Characterization of parathyroid hormone receptors in canine renal cortical plasma membranes using a radioiodinated sulfur-free hormone analogue. Correlation of binding with adenylate cyclase activity. J Biol Chem (1979) 1.11
A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog. Science (1983) 1.10
Backbone cyclization: A new method for conferring conformational constraint on peptides. Biopolymers (1991) 1.09
Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone (1998) 1.08
Demonstration of post-translational secretion of human placental lactogen by a mammalian in vitro translation system. J Biol Chem (1986) 1.08
Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice. J Bone Miner Res (2001) 1.08
Parathyroid hormone inhibitors. Design, synthesis, and biologic evaluation of hormone analogues. J Biol Chem (1977) 1.07
Permanent loss in stem cell self renewal capacity following stress to the marrow. Blood (1988) 1.07
Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management. Int Angiol (2013) 1.06
Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J (1992) 1.06
Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? Bone (1997) 1.04
Coexpression of Drosophila TRP and TRP-like proteins in Xenopus oocytes reconstitutes capacitative Ca2+ entry. Proc Natl Acad Sci U S A (1996) 1.04
The synthetic precursor specific region of pre-pro-parathyroid hormone forms ion channels in lipid bilayers. Biosci Rep (1988) 1.03
Plasma melatonin increases during exercise in women. J Clin Endocrinol Metab (1981) 1.03
Binding domain of human parathyroid hormone receptor: from conformation to function. Biochemistry (1998) 1.02
Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone (1999) 1.01
1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast-supporting stromal cells. J Cell Biochem (1999) 1.01
[pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype. J Med Chem (1986) 1.01
A role for N-cadherin in the development of the differentiated osteoblastic phenotype. J Bone Miner Res (2000) 1.00
Characterization of parathyroid hormone/receptor interactions: structure of the first extracellular loop. Biochemistry (2000) 1.00
Cellular processing of pre-proparathyroid hormone involves rapid hydrolysis of the leader sequence. J Biol Chem (1979) 1.00
Apparent G-monosomy, G-deletion, and incomplete Down's syndrome in a single family. J Med Genet (1972) 1.00
Desensitization with a selective agonist discriminates between multiple tachykinin receptors. J Pharmacol Exp Ther (1988) 1.00
Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor. Biochemistry (1996) 0.99
Primary structure of peptides and ion channels. Role of amino acid side chains in voltage gating of melittin channels. Biophys J (1990) 0.99
Production of active immunity to malignant neoplastic tissue. Chemical coupling to an antigenic protein carrier. Cancer (1966) 0.98
Chemical and biological properties of synthetic, sulfur-free analogues of parathyroid hormone. J Biol Chem (1976) 0.98
Parathyroid hormone inhibitors: comparison of biological activity in bone- and skin-derived tissue. J Clin Endocrinol Metab (1979) 0.98
Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide. J Clin Endocrinol Metab (1981) 0.98
Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol (2001) 0.98
Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res (1982) 0.97
Mental retardation and congenital malformations associated with a ring chromosome 6. Clin Genet (1975) 0.97
Peripheral vascular occlusive disease: accuracy and reliability of time-of-flight MR angiography. Radiology (1994) 0.96
Inhibition of insulin-dependent lipogenesis and anti-lipolysis by protein tyrosine kinase inhibitors. EMBO J (1989) 0.96
Solid-phase synthesis of melittin: purification and functional characterization. Biochemistry (1987) 0.95
Coupling of the PTH/PTHrP receptor to multiple G-proteins. Direct demonstration of receptor activation of Gs, Gq/11, and Gi(1) by [alpha-32P]GTP-gamma-azidoanilide photoaffinity labeling. Endocrine (1998) 0.94
Hepatic artery ligation. Surgery (1979) 0.93
RoBo-1, a novel member of the urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family selectively expressed in rat bone and growth plate cartilage. J Biol Chem (1998) 0.92
Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity crosslinking. Proc Natl Acad Sci U S A (1997) 0.91
Mitogenic G(i) protein-MAP kinase signaling cascade in MC3T3-E1 osteogenic cells: activation by C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)] and attenuation of activation by cAMP. J Cell Biochem (2001) 0.91
Direct action of the parathyroid hormone-like human hypercalcemic factor on bone. Proc Natl Acad Sci U S A (1988) 0.90
Conformational consequences of i, i + 3 cystine linkages: nucleation for alpha-helicity? J Pept Res (1997) 0.90